607 related articles for article (PubMed ID: 26268315)
1. An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease.
Zhang S; Ermann J; Succi MD; Zhou A; Hamilton MJ; Cao B; Korzenik JR; Glickman JN; Vemula PK; Glimcher LH; Traverso G; Langer R; Karp JM
Sci Transl Med; 2015 Aug; 7(300):300ra128. PubMed ID: 26268315
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease.
Kotla NG; Singh R; Baby BV; Rasala S; Rasool J; Hynes SO; Martin D; Egan LJ; Vemula PK; Jala VR; Rochev Y; Pandit A
Biomaterials; 2022 Feb; 281():121364. PubMed ID: 35066288
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles for the regulation of intestinal inflammation: opportunities and challenges.
Nunes R; Neves JD; Sarmento B
Nanomedicine (Lond); 2019 Oct; 14(19):2631-2644. PubMed ID: 31612773
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
Nakase H; Okazaki K; Tabata Y; Chiba T
J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
[TBL] [Abstract][Full Text] [Related]
5. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
6. Current pharmaceutical strategies for efficient site specific delivery in inflamed distal intestinal mucosa.
Sharma S; Sinha VR
J Control Release; 2018 Feb; 272():97-106. PubMed ID: 29317245
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
Yang C; Merlin D
Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
[TBL] [Abstract][Full Text] [Related]
8. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
9. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
10. Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients.
Schmidt C; Lautenschlaeger C; Collnot EM; Schumann M; Bojarski C; Schulzke JD; Lehr CM; Stallmach A
J Control Release; 2013 Jan; 165(2):139-45. PubMed ID: 23127508
[TBL] [Abstract][Full Text] [Related]
11. Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease.
Date AA; Rais R; Babu T; Ortiz J; Kanvinde P; Thomas AG; Zimmermann SC; Gadiano AJ; Halpert G; Slusher BS; Ensign LM
J Control Release; 2017 Oct; 263():132-138. PubMed ID: 28159515
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model.
Melero A; Draheim C; Hansen S; Giner E; Carreras JJ; Talens-Visconti R; Garrigues TM; Peris JE; Recio MC; Giner R; Lehr CM
Eur J Pharm Biopharm; 2017 Oct; 119():361-371. PubMed ID: 28709903
[TBL] [Abstract][Full Text] [Related]
13. Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.
Smrdel P; Cerne M; Bogataj M; Urleb U; Mrhar A
J Microencapsul; 2010; 27(7):572-82. PubMed ID: 20690794
[TBL] [Abstract][Full Text] [Related]
14. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
[TBL] [Abstract][Full Text] [Related]
15. Macromolecular glucocorticoid prodrug improves the treatment of dextran sulfate sodium-induced mice ulcerative colitis.
Ren K; Yuan H; Zhang Y; Wei X; Wang D
Clin Immunol; 2015 Sep; 160(1):71-81. PubMed ID: 25869296
[TBL] [Abstract][Full Text] [Related]
16. Thermosensitive polymer hydrogel as a physical shield on colonic mucosa for colitis treatment.
Guo Z; Bai Y; Zhang Z; Mei H; Li J; Pu Y; Zhao N; Gao W; Wu F; He B; Xie J
J Mater Chem B; 2021 May; 9(18):3874-3884. PubMed ID: 33928321
[TBL] [Abstract][Full Text] [Related]
17. Colon-Adhering Delivery System with Inflammation Responsiveness for Localized Therapy of Experimental Colitis.
Kumar A; Kanika ; Kumar V; Ahmad A; Mishra RK; Nadeem A; Siddiqui N; Ansari MM; Raza SS; Kondepudi KK; Khan R
ACS Biomater Sci Eng; 2023 Aug; 9(8):4781-4793. PubMed ID: 37497615
[TBL] [Abstract][Full Text] [Related]
18. A 3-D artificial colon tissue mimic for the evaluation of nanoparticle-based drug delivery system.
Huang Z; Wang Z; Long S; Jiang H; Chen J; Zhang J; Dong L
Mol Pharm; 2014 Jul; 11(7):2051-61. PubMed ID: 24456069
[TBL] [Abstract][Full Text] [Related]
19. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells.
Sasaoka T; Ito M; Yamashita J; Nakajima K; Tanaka I; Narita M; Hara Y; Hada K; Takahashi M; Ohno Y; Matsuo T; Kaneshiro Y; Tanaka H; Kaneko K
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G568-76. PubMed ID: 21193526
[TBL] [Abstract][Full Text] [Related]
20. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.
Hua S; Marks E; Schneider JJ; Keely S
Nanomedicine; 2015 Jul; 11(5):1117-32. PubMed ID: 25784453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
